Development of intraoperative electrochemical detection: wireless instantaneous neurochemical concentration sensor for deep brain stimulation feedback.

Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA.
Neurosurgical FOCUS (Impact Factor: 2.14). 08/2010; 29(2):E6. DOI: 10.3171/2010.5.FOCUS10110
Source: PubMed

ABSTRACT Deep brain stimulation (DBS) is effective when there appears to be a distortion in the complex neurochemical circuitry of the brain. Currently, the mechanism of DBS is incompletely understood; however, it has been hypothesized that DBS evokes release of neurochemicals. Well-established chemical detection systems such as microdialysis and mass spectrometry are impractical if one is assessing changes that are happening on a second-to-second time scale or for chronically used implanted recordings, as would be required for DBS feedback. Electrochemical detection techniques such as fast-scan cyclic voltammetry (FSCV) and amperometry have until recently remained in the realm of basic science; however, it is enticing to apply these powerful recording technologies to clinical and translational applications. The Wireless Instantaneous Neurochemical Concentration Sensor (WINCS) currently is a research device designed for human use capable of in vivo FSCV and amperometry, sampling at subsecond time resolution. In this paper, the authors review recent advances in this electrochemical application to DBS technologies. The WINCS can detect dopamine, adenosine, and serotonin by FSCV. For example, FSCV is capable of detecting dopamine in the caudate evoked by stimulation of the subthalamic nucleus/substantia nigra in pig and rat models of DBS. It is further capable of detecting dopamine by amperometry and, when used with enzyme linked sensors, both glutamate and adenosine. In conclusion, WINCS is a highly versatile instrument that allows near real-time (millisecond) detection of neurochemicals important to DBS research. In the future, the neurochemical changes detected using WINCS may be important as surrogate markers for proper DBS placement as well as the sensor component for a "smart" DBS system with electrochemical feedback that allows automatic modulation of stimulation parameters. Current work is under way to establish WINCS use in humans.


Available from: Kevin Bennet, Jun 12, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Developments in neurotechnology are recently driven by newly national and international brain research initiatives worldwide. The challenging goal of understanding how the human brain works requires a vast amount of information gained by neural sensors. Microelectrodes implanted in the central nervous system are extensively used to record electric activity inside the brain tissue. More recently, deep-brain stimulation in Parkinson disease proved the feasibility of such electrodes in human medical treatments as well. To add novel sensor or even actuator functions to these microelectrodes, limitations of recent fabrication technologies have to be considered. To date, silicon microtechnology offered the highest potential to meet the demands of neural applications regarding multiple functions integrated on a single implantable microsystem. Besides reproducibility and low variability of silicon-based microelectrodes, combination of various functionalities like standard electrophysiology, integrated signal processing, local drug delivery, neurochemical detection and optogenetic stimulation is also possible using these microsystems. This ability makes silicon microelectrodes good candidates to provide high-resolution recording and stimulation in the electric, fluidic, chemical or optical domain in more complex neurophysiological experiments in the future.
    Sensors and Actuators B Chemical 08/2015; 215. DOI:10.1016/j.snb.2015.03.055 · 3.84 Impact Factor
  • Neuroethics 12/2014; 7(3):253-261. DOI:10.1007/s12152-014-9204-5 · 1.04 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Since the early 70s electrochemistry has been used as a powerful analytical technique for monitoring electroactive species in living organisms. In particular, after extremely rapid evolution of new micro and nanotechnology it has been established as an invaluable technique ranging from experiments in vivo to measurement of exocytosis during communication between cells under in vitro conditions. This review highlights recent advances in the development of electrochemical sensors for selective sensing of one of the most important neurotransmitters-dopamine. Dopamine is an electroactive catecholamine neurotransmitter, abundant in the mammalian central nervous system, affecting both cognitive and behavioral functions of living organisms. We have not attempted to cover a large time-span nor to be comprehensive in presenting the vast literature devoted to electrochemical dopamine sensing. Instead, we have focused on the last five years, describing recent progress as well as showing some problems and directions for future development.
    Analytical and Bioanalytical Chemistry 12/2012; 405(11). DOI:10.1007/s00216-012-6578-2 · 3.58 Impact Factor